New England Biolabs (United States)
New England Biolabs is an American life sciences company which produces and supplies recombinant and native enzyme reagents for life science research. It also provides products and services supporting genome editing, synthetic biology and next-generation sequencing. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for New England Biolabs (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
75%
Total
Publications
1.8K
Total Open
Publications
1.4K
Total
Citations
106K
Open Access
Percentage
75%
Total
Publications
1.8K
Total Open
Publications
1.4K
Total
Citations
106K
Breakdown
Publisher Open
10%
Both
46%
Other Platform Open
19%
Closed
25%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 49%
502
Hybrid 32%
327
No Guarantees 19%
192
Other Platform Open
Domain 85%
1K
Public 16%
189
Institution 15%
181
Preprint 14%
162
Other Internet 13%
155
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 1K |
Europe PMC | Domain | 695 |
Semantic Scholar | Public | 176 |
bioRxiv | Preprint | 130 |
DOI | Other Internet | 83 |
Research Square | Preprint | 31 |
Unknown Repository | Other Internet | 27 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 20 |
Harvard University - Digital Access to Scholarship at Harvard (DASH) | Institution | 20 |
University of Edinburgh - Edinburgh Research Explorer | Institution | 19 |